tirzepatide-peptides-for-researchtirzepatide-peptides-for-research The field of nasal pulmonary peptide delivery is rapidly evolving, with numerous companies dedicating significant resources to developing innovative methods for administering peptide-based therapeutics. The inherent advantages of the nasal route, such as its non-invasive nature and direct pathway to the brain, make it a highly attractive option for delivering peptides, which often face challenges with oral bioavailability and stability. This article explores the leading companies at the forefront of this critical area of drug delivery.
Several prominent companies are recognized for their contributions to both nasal and pulmonary drug delivery systems, with some focusing specifically on peptide therapeutics. These organizations leverage advanced technologies to enhance the efficacy and patient acceptance of these delivery methods.Thenasalroute offers several advantages for thedeliveryofpeptidesas a non-invasive and effective method.
* GlaxoSmithKline (GSK) is a major player with a broad portfolio, including nasal sprays for both vaccines and therapeutics, addressing respiratory conditions.作者：SS Davis·1999·被引用次数：103—Thenasalroute can also be used for thedeliveryof vaccines. This review makes a comparison betweennasalandpulmonary delivery. Section ... Their extensive experience in developing and commercializing nasal sprays positions them as a leader in the market作者：D Luo·2024·被引用次数：23—In this paper, we reviewed the achievements of 18peptidedrugs in the past decade about the perspectives of the efficacy, mechanism of enhancing intranasal ....
* AstraZeneca is another pharmaceutical giant actively involved in developing advanced drug delivery systems, including those for nasal and pulmonary administration. Their research often targets respiratory diseases and other conditions where these routes offer therapeutic advantages.
* Kindeva Drug Delivery brings over a century of innovation to the field, offering expertise across pulmonary, nasal, injectable, and transdermal therapies作者：W Alabsi·2022·被引用次数：97—This review highlights the intranasaldeliveryof drugs, focusing onpeptide delivery, illustrating various clinical applications,nasal deliverydevices,. They are instrumental in developing sophisticated delivery devices and formulations.
* Baxter International contributes advanced nasal delivery solutions, catering to both emergency and chronic care needs, highlighting the versatility of nasal administration.
* AptarGroup specializes in the design and manufacturing of nasal spray devices, focusing on the engineering aspects crucial for effective and user-friendly drug delivery.
While many companies offer general drug delivery solutions, a select few are specifically advancing the science of peptide delivery via nasal and pulmonary routes. The unique properties of peptides, such as their susceptibility to enzymatic degradation and poor oral absorption, necessitate specialized delivery strategies.
* Tiziana Life Sciences is noted for its work in nasal drug delivery, potentially including peptide-based therapies. Their efforts are crucial in exploring novel applications for the nasal route.
* Ethris is recognized for its work in pulmonary drug delivery, which can be adapted for peptide delivery to the lungs.
* Respira Therapeutics, Inc.2024年4月18日—Each issue focuses on a specific topic within the field ofdrug delivery, and is supported by industry leaders in that field. EDITORIAL CALENDAR ... is actively engaged in developing pulmonary drug delivery solutions, which is a key area for delivering certain peptide therapeutics directly to the lungs.作者：W Alabsi·2022·被引用次数：97—This review highlights the intranasaldeliveryof drugs, focusing onpeptide delivery, illustrating various clinical applications,nasal deliverydevices,
* Okyo Pharma is also involved in the nasal drug delivery space, contributing to the ongoing innovation in this fieldNose-to-Brain Delivery of Therapeutic Peptides as Nasal ....
The research into nasal drug delivery and pulmonary delivery for peptides is driven by the pursuit of more effective and less invasive treatment options. Studies highlight the potential of the nasal route for nose-to-brain delivery of therapeutic peptides, opening new avenues for treating neurological disorders. Furthermore, advancements in nanotechnology and formulation science are enabling more efficient encapsulation and targeted release of peptides, overcoming previous limitations.
The development of drug delivery systems that can successfully transport peptides through the nasal or pulmonary pathways is a complex scientific endeavor. Companies are investing heavily in research and development to create devices and formulations that can protect peptides from degradation, enhance their absorption, and ensure consistent therapeutic outcomes. The ongoing exploration of these delivery methods promises to significantly expand the therapeutic applications of peptide drugs in the coming years.
Join the newsletter to receive news, updates, new products and freebies in your inbox.